Skip to main content

Table 1 Clinical characteristics of the study groups

From: Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study

 At-risk women without PEAt-risk women with PEp-value
n11932 
Maternal Characteristics
 Gestational age at sample collection (wk)29 (8.5)30 (7.3)0.14
 Maternal age (yr)33 (7.5)33 (6.5)0.74
 Maternal weight pre-pregnancy (kg)68 (23.8)65.5 (16.5.)0.7
 Maternal weight at sample collection (kg)78 (22.8)80 (15.5)0.71
 Maternal BMI (kg/m2)24.16 (7.8)25.67 (5.5)0.96
 Systolic BP (mmHg)124 (19)160 (39)< 0.001
 Days before delivery54 (72)4 (10.8)< 0.001
 Ethnicity: Caucasian100 (84%)23 (72%)0.08
 Nulliparity64 (54%)20 (63%)0.5
Co-morbidities
 Pre-existing chronic renal disease7 (6%)3 (9%)0.69
 Pre-existing diabetes4 (3%)0 (0%)0.67
 Pre-existing hypertension21 (18%)9 (28%)0.5
 Gestational diabetes28 (24%)3 (9%)0.13
 Gestational hypertension15 (13%)6 (19%)0.03
Delivery Outcomes
 Gestational age at delivery (wk)38.71 (2.9)30.64 (8)< 0.001
 Birth weight (g)2980 (12.1)1270 (1387.5)< 0.001
 Apgar score 5 min9 (2)8 (2)< 0.001
 Mode of delivery: C-section72 (61%)26 (81%)0.14
 Preterm < 34 weeks33 (28%)28 (88%)< 0.001
 Small for Gestational Age (SGA)10 (8%)1 (3%)0.31
 Intrauterine growth restriction (IUGR)27 (23%)15 (47%)0.01
  1. Data are displayed as median (IQR) or n (%). Continuous variables were compared via Wilcoxon rank sum test, categorical variables were compared using χ2 test
  2. BMI body mass index, kg kilogram, PE preeclampsia, wk week, yr year